Possibilities of microemulsion application in rectal administration of indomethacin

[1] ADC.sk. Indomethacin. Available at https://www.adc.sk/databazy/produkty/detail/indometacin-100-berlin-chemie-439509.html (Accessed 14 June 2021). ADC.sk Indomethacin Available at https://www.adc.sk/databazy/produkty/detail/indometacin-100-berlin-chemie-439509.html (Accessed 14 June 2021). Search in Google Scholar

[2] Alsamman A, Othman M. Preparation and in vitro evaluation of fast release diazepam suppositories for febrile seizures. Asian J Pharm Clin Res. 2017;10:224–230. AlsammanA OthmanM Preparation and in vitro evaluation of fast release diazepam suppositories for febrile seizures Asian J Pharm Clin Res 2017 10 224 230 10.22159/ajpcr.2017.v10i9.19264 Search in Google Scholar

[3] Blumer JL. Principles of drug disposition in the critically ill child. In Fuhrman BP & Zimmerman JJ. Pediatric Critical Care: Saint Louis: Mosby; 2011. BlumerJL Principles of drug disposition in the critically ill child In FuhrmanBP ZimmermanJJ Pediatric Critical Care Saint Louis Mosby 2011 10.1016/B978-0-323-07307-3.10116-8 Search in Google Scholar

[4] Constantin IO. Development of misoprostol suppositories for postpartum hemorrhage. Pharmacol Pharm. 2013;4:71–76. ConstantinIO Development of misoprostol suppositories for postpartum hemorrhage Pharmacol Pharm 2013 4 71 76 10.4236/pp.2013.41010 Search in Google Scholar

[5] Council of Europe. European pharmacopoeia 10.0: Softening time determination of lipophilic suppositories (chapter 2.9.22). Strassbourg: EDQM; 2019. Council of Europe European pharmacopoeia 10.0: Softening time determination of lipophilic suppositories (chapter 2.9.22) Strassbourg EDQM 2019 Search in Google Scholar

[6] Gugulothu D, Pathak S, Suryavanshi S, Sharma S, Patravale V. Self-microemulsifiyng suppository formulation of β-artemether. AAPS PharmSciTech. 2010;11:1,179–1,184. GugulothuD PathakS SuryavanshiS SharmaS PatravaleV Self-microemulsifiyng suppository formulation of β-artemether AAPS PharmSciTech 2010 11 1,179 1,184 10.1208/s12249-010-9478-9297412520661674 Search in Google Scholar

[7] Hanaee J, Javadzadeh Y, Taftachi S, Farid D, Nokhodchi A. The role of various surfactants on the release of salbutamol from suppositories. Farmaco. 2004; 59: 903–906. HanaeeJ JavadzadehY TaftachiS FaridD NokhodchiA The role of various surfactants on the release of salbutamol from suppositories Farmaco 2004 59 903 906 10.1016/j.farmac.2004.07.00615544795 Search in Google Scholar

[8] Hua S. Physiological and pharmaceutical considerations for rectal drug formulations. Front Pharmacol. 2019;10:1,196. HuaS Physiological and pharmaceutical considerations for rectal drug formulations Front Pharmacol 2019 10 1,196 10.3389/fphar.2019.01196680570131680970 Search in Google Scholar

[9] Melo M, Nunes R, Sarmento B, Neves J. Rectal administration of nanosystems: From drug delivery to diagnostics. Mater Today Chem. 2018;10:128–141. MeloM NunesR SarmentoB NevesJ Rectal administration of nanosystems: From drug delivery to diagnostics Mater Today Chem 2018 10 128 141 10.1016/j.mtchem.2018.09.001 Search in Google Scholar

[10] Sah M, Saini T. Formulation Development and Release Studies of Indomethacin Suppositories. Indian J Pharm Sci. 2008;70:498–501. SahM SainiT Formulation Development and Release Studies of Indomethacin Suppositories Indian J Pharm Sci 2008 70 498 501 10.4103/0250-474X.44602279255920046779 Search in Google Scholar

[11] Szulc-Musiol B, Bulas L, Dolinska B. Effect of Selected Surfactants on Kinetics of Meloxicam Release from Rectal Suppositories. Indian J Pharm Sci. 2019;81:1,115–1,121. Szulc-MusiolB BulasL DolinskaB Effect of Selected Surfactants on Kinetics of Meloxicam Release from Rectal Suppositories Indian J Pharm Sci 2019 81 1,115 1,121 10.36468/pharmaceutical-sciences.610 Search in Google Scholar